CeriBell Inc.

CBLL | NASDAQ

Price Alert Chart Builder DCF Calculator

$24.25

-$0.12 (-0.49%)

At close: Sep 21, 2026, 4:00 PM ET

$24.73

+$0.48 (+1.98%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.49%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $920.11M

1D Range

24.02 24.48

52W Range

10.85 25.63

Valuation (TTM)

PE -13.78

PB 7.17

EV/EBITDA -12.89

Valuation (NTM)

Forward PE N/A

Forward PEG 0.75

Price Target $27.50

Cash Flow

FCF Yield -6.1%

SBC Adj. FCF Yield -7.9%

SBC Impact -29.2%

Margins

Gross Margin 88.9%

Operating Margin -68.6%

FCF Margin -55.3%

Growth (CAGR)

Revenue 3Y | 5Y 70.8% | N/A

Dil EPS 3Y | 5Y -20.6% | N/A

FCF 3Y | 5Y -28.9% | N/A

Returns

ROA -39.7%

ROE -44.9%

ROIC -46.5%

Financial Health

Net Cash

$107.35M

Current Ratio 9.18

Interest Coverage -38.57

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions direc...

Sector Healthcare

Industry Medical - Devices

Employees 327

IPO Date Oct 10, 2024

Website ceribell.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$27.50

Upside

+13.40%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞